Product Introduction       “Newgenco Nuotong Natto Capsule” was manufactured from Natto extract by further improvement the content and activity of Natto Kinase, which provides the innovation and effective healthcare solution for thrombus disease, hyperlipidemia, hypertension, strokes, heart attack and other cardiovascular diseases. Quality Criteria Soybean isoflavonoid > 120mg/ 100g Natto Kinase > 2000FU/g Water < 9% Ash < 8% Lead < 0.5ppm Arsenic < 1ppm Mercury < 0.3ppm Core Technology Natto is fermented soybean that is a traditional Japanese staple for more than 1,000 years. Recently its medical benefits are widely recognized in resulting in its increased popularity. Some of its beneficial effects are prevention of heart attacks, strokes, cancer, osteoporosis, obesity and intestinal disease caused by pathogens. Some of the effects are attributed to its soybean origin. “Newgenco Nuotong Natto Capsule” was manufactured in GMP standard by our patented techniques. We discovered that the production of Natto kinase was significantly increased by adjusting fermentation conditions. We have further developed a set of technology to keep Natto kinase activity by vaccum freeze drier and to control the quality standard of various active compounds via unique fermentation technology. This technology was submitted out for patent application in in July, 2005. Patent: A method for manufacturing freeze dried natto, application number: 200510027740.5).